Some of Wall Street’s biggest names are exposed to the Adani Enterprises plunge

Posted by & filed under Company Analysis, Economic Analysis, Financial analysis, Management Issues, Market Analysis, Personal Finance.

Description: Shares of India’s Adani Enterprises have plummeted over the past week, after the publication of an extensive critical report from U.S. short-seller Hindenburg Research. Some big international players have exposure. Source: CNBC.com – video report Date: Feb 03, 2023 Link: https://www.cnbc.com/2023/02/03/some-of-wall-streets-biggest-names-are-exposed-to-the-adani-enterprises-plunge.html Questions for discussion: What does the report say about Adani Enterprises? Why is this story a concern… Read more »

Investors made up 20 to 30% of homeowners in some provinces: Statistics Canada

Posted by & filed under Economic Analysis, Financial analysis, Governments & Regulators, Industry Analysis, Market Analysis, Personal Finance.

Description: New Statistics Canada data shows investors made up almost one third of homeowners in some provinces in 2020. Source: BNNBloomberg.ca – video report Date: Feb 03, 2023 Link: https://www.bnnbloomberg.ca/investors-made-up-20-to-30-of-homeowners-in-some-provinces-statistics-canada-1.1879113 Questions for discussion: What does the report say about who owns homes and condos as an investment? What does this mean in terms of valuations… Read more »

Jobs report shows increase of 517,000 in January, crushing estimates, as unemployment rate hit 53-year low

Posted by & filed under Economic Analysis, Governments & Regulators, Growth & Valuation, Personal Finance.

Description: The employment picture started off 2023 on a stunningly strong note, with nonfarm payrolls posting their biggest gain since July 2022. Source: CNBC.com – video report Date: Feb 03, 2023 Link: https://www.cnbc.com/2023/02/03/jobs-report-january-2023-.html Questions for discussion: Where were the main growth areas for employment? What does this say about how the economy is recovering from… Read more »

How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

Posted by & filed under Company Analysis, Economic Analysis, Financial analysis, Financial Planning, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues, Market Analysis, Personal Finance.

Description: AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end. Source: NYTimes.com Date: Jan 28, 2023 Link: https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html Questions for discussion: Summarize the issues related to how businesses, governments, insurance companies and consumers are connected to the drug Humira. Is this… Read more »